ONESOURCE
Invest with MTF
Invest Now
Invest in OneSource Specialty Pharma with 3.09X leverage
Performance
- Low
- ₹1,650
- High
- ₹1,691
- 52 Week Low
- ₹1,210
- 52 Week High
- ₹2,248
- Open Price₹1,659
- Previous Close₹1,668
- Volume197,165
Investment Returns
- Over 1 Month -8.06%
- Over 3 Month -10.31%
- Over 6 Month -13.49%
- Over 1 Year + 0.95%
Smart Investing Starts Here Start SIP with OneSource Specialty Pharma for Steady Growth!
OneSource Specialty Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 483.2
- PEG Ratio
- 4.1
- Market Cap Cr
- 19,307
- P/B Ratio
- Average True Range
- 62.37
- EPS
- 12.04
- Dividend Yield
- 0
- MACD Signal
- -50.31
- RSI
- 48.48
- MFI
- 38.38
OneSource Specialty Pharma Financials
OneSource Specialty Pharma Technicals
EMA & SMA
Current Price
₹1,685.80
+
18
(1.08%)
- Bearish Moving Average 9
- Bullish Moving Average 7
- 20 Day
- ₹1,676.41
- 50 Day
- ₹1,745.44
- 100 Day
- ₹1,776.00
- 200 Day
- ₹1,741.46
Resistance and Support
1675.47
- R3 1,741.83
- R2 1,716.27
- R1 1,701.03
- S1 1,660.23
- S2 1,634.67
- S3 1,619.43
OneSource Specialty Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-11 | Quarterly Results | |
| 2025-08-04 | Quarterly Results | |
| 2025-05-05 | Audited Results | |
| 2025-01-29 | Quarterly Results |
OneSource Specialty Pharma F&O
About OneSource Specialty Pharma
- NSE Symbol
- ONESOURCE
- BSE Symbol
- 544292
- Managing Director & CEO
- Mr. Neeraj Sharma
- ISIN
- INE013P01021
Similar Stocks to OneSource Specialty Pharma
OneSource Specialty Pharma FAQs
OneSource Specialty Pharma share price is ₹1,685 As on 06 December, 2025 | 05:34
The Market Cap of OneSource Specialty Pharma is ₹19306.7 Cr As on 06 December, 2025 | 05:34
The P/E ratio of OneSource Specialty Pharma is 483.2 As on 06 December, 2025 | 05:34
The PB ratio of OneSource Specialty Pharma is 3.3 As on 06 December, 2025 | 05:34
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.